Pricing
Login
Home
Charts
Search
Watchlist
Products

Lupin Ltd

₹2,014.00+0.76%20 Nov 2026
Reports
Pharma Formulations

Lupin Ltd

₹2,014.00
+0.76%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹92,099Cr
Close
Close Price
₹2,014.00
Industry
Industry
Pharma Formulations
PE
Price To Earnings
17.24
PS
Price To Sales
3.00
Revenue
Revenue
₹30,746Cr
Rev Gr TTM
Revenue Growth TTM
24.22%
PAT Gr TTM
PAT Growth TTM
20.10%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
5,1974,9615,6005,6735,7685,6676,2687,0487,1687,4758,2777,827
Growth YoY
Revenue Growth YoY%
20.312.016.312.611.014.211.924.224.331.932.011.1
Expenses
ExpensesCr
4,1593,9644,3594,3324,4124,3464,5414,7064,9064,9895,8275,783
Operating Profit
Operating ProfitCr
1,0389971,2411,3401,3561,3211,7272,3412,2622,4862,4502,044
OPM
OPM%
20.020.122.223.623.523.327.633.231.633.329.626.1
Other Income
Other IncomeCr
2929684254577990-3129130127
Interest Expense
Interest ExpenseCr
74716871678992108115120110106
Depreciation
DepreciationCr
257457248257271393299317313447453486
PBT
PBTCr
7364989931,0551,0718961,4162,0071,5221,9282,0171,580
Tax
TaxCr
117129187195212113194522342459600424
PAT
PATCr
6193688068598597821,2211,4851,1811,4691,4171,155
Growth YoY
PAT Growth YoY%
292.451.977.773.538.8112.551.672.837.587.716.0-22.2
NPM
NPM%
11.97.414.415.214.913.819.521.116.519.617.114.8
EPS
EPS₹
13.57.917.618.718.816.926.732.425.734.830.925.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
5,1974,9615,6005,6735,7685,6676,2687,0487,1687,4758,2777,827
Growth YoY
Revenue Growth YoY%
20.312.016.312.611.014.211.924.224.331.932.011.1
Expenses
ExpensesCr
4,1593,9644,3594,3324,4124,3464,5414,7064,9064,9895,8275,783
Operating Profit
Operating ProfitCr
1,0389971,2411,3401,3561,3211,7272,3412,2622,4862,4502,044
OPM
OPM%
20.020.122.223.623.523.327.633.231.633.329.626.1
Other Income
Other IncomeCr
2929684254577990-3129130127
Interest Expense
Interest ExpenseCr
74716871678992108115120110106
Depreciation
DepreciationCr
257457248257271393299317313447453486
PBT
PBTCr
7364989931,0551,0718961,4162,0071,5221,9282,0171,580
Tax
TaxCr
117129187195212113194522342459600424
PAT
PATCr
6193688068598597821,2211,4851,1811,4691,4171,155
Growth YoY
PAT Growth YoY%
292.451.977.773.538.8112.551.672.837.587.716.0-22.2
NPM
NPM%
11.97.414.415.214.913.819.521.116.519.617.114.8
EPS
EPS₹
13.57.917.618.718.816.926.732.425.734.830.925.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
14,13217,36715,79714,66515,37515,16316,40516,64220,01122,70827,95830,746
Growth
Revenue Growth%
10.722.9-9.0-7.24.8-1.48.21.420.313.523.124.2
Expenses
ExpensesCr
10,44612,87412,64912,10413,02012,59616,18714,92116,21117,43019,79921,505
Operating Profit
Operating ProfitCr
3,6854,4933,1482,5612,3552,5672191,7213,8005,2788,1609,241
OPM
OPM%
26.125.919.917.515.316.91.310.319.023.229.230.1
Other Income
Other IncomeCr
190115-1,310-3-264138210151131202523-45
Interest Expense
Interest ExpenseCr
59153204302363141143274312295434450
Depreciation
DepreciationCr
4879121,0868469708871,6598811,1971,1691,3761,699
PBT
PBTCr
3,3293,5435471,4097571,676-1,3727162,4224,0156,8737,047
Tax
TaxCr
1,0599792888881,1574491372694877091,5171,826
PAT
PATCr
2,2702,565258521-4001,228-1,5094481,9363,3065,3555,221
Growth
PAT Growth%
-7.213.0-89.9101.7-176.8407.1-222.9129.7332.470.862.020.1
NPM
NPM%
16.114.81.63.5-2.68.1-9.22.79.714.619.217.0
EPS
EPS₹
50.356.75.613.6-6.026.8-33.69.542.072.0116.8116.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
14,13217,36715,79714,66515,37515,16316,40516,64220,01122,70827,95830,746
Growth
Revenue Growth%
10.722.9-9.0-7.24.8-1.48.21.420.313.523.124.2
Expenses
ExpensesCr
10,44612,87412,64912,10413,02012,59616,18714,92116,21117,43019,79921,505
Operating Profit
Operating ProfitCr
3,6854,4933,1482,5612,3552,5672191,7213,8005,2788,1609,241
OPM
OPM%
26.125.919.917.515.316.91.310.319.023.229.230.1
Other Income
Other IncomeCr
190115-1,310-3-264138210151131202523-45
Interest Expense
Interest ExpenseCr
59153204302363141143274312295434450
Depreciation
DepreciationCr
4879121,0868469708871,6598811,1971,1691,3761,699
PBT
PBTCr
3,3293,5435471,4097571,676-1,3727162,4224,0156,8737,047
Tax
TaxCr
1,0599792888881,1574491372694877091,5171,826
PAT
PATCr
2,2702,565258521-4001,228-1,5094481,9363,3065,3555,221
Growth
PAT Growth%
-7.213.0-89.9101.7-176.8407.1-222.9129.7332.470.862.020.1
NPM
NPM%
16.114.81.63.5-2.68.1-9.22.79.714.619.217.0
EPS
EPS₹
50.356.75.613.6-6.026.8-33.69.542.072.0116.8116.8
Sales CAGR
1 Year23%
3 Years19%
5 Years13%
TTM24%
EBITDA CAGR
1 Year55%
3 Years68%
5 Years26%
TTM37%
PAT CAGR
1 Year62%
3 Years129%
5 Years34%
TTM20%
Avg. ROCE
1 Year25%
3 Years20%
5 Years12%
TTM25%
CFO / EBITDA
1 Year90%
3 Years81%
5 Years85%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
909090919191919191919191
Reserves
ReservesCr
11,07313,40713,48713,65212,44613,71212,06212,37414,19917,11222,35723,959
Current Liabilities
Current LiabilitiesCr
5,0616,1215,0966,1309,2258,4368,4989,2658,5028,96112,65112,541
Non Current Liabilities
Non Current LiabilitiesCr
6,3686,9557,5938,0303,1771,3161,1011,1481,1222,9493,2003,319
Total Liabilities
Total LiabilitiesCr
22,62526,60726,30527,94924,98423,61021,82122,95623,99729,20538,36539,911
Current Assets
Current AssetsCr
9,88711,95312,21013,85415,41313,98612,45812,45113,44816,79924,02723,070
Non Current Assets
Non Current AssetsCr
12,73714,65414,09614,0969,5719,6249,36410,50510,55012,40614,33716,841
Total Assets
Total AssetsCr
22,62526,60726,30527,94924,98423,61021,82122,95623,99729,20538,36539,911
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
909090919191919191919191
Reserves
ReservesCr
11,07313,40713,48713,65212,44613,71212,06212,37414,19917,11222,35723,959
Current Liabilities
Current LiabilitiesCr
5,0616,1215,0966,1309,2258,4368,4989,2658,5028,96112,65112,541
Non Current Liabilities
Non Current LiabilitiesCr
6,3686,9557,5938,0303,1771,3161,1011,1481,1222,9493,2003,319
Total Liabilities
Total LiabilitiesCr
22,62526,60726,30527,94924,98423,61021,82122,95623,99729,20538,36539,911
Current Assets
Current AssetsCr
9,88711,95312,21013,85415,41313,98612,45812,45113,44816,79924,02723,070
Non Current Assets
Non Current AssetsCr
12,73714,65414,09614,0969,5719,6249,36410,50510,55012,40614,33716,841
Total Assets
Total AssetsCr
22,62526,60726,30527,94924,98423,61021,82122,95623,99729,20538,36539,911

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-3824,1141,7511,6661,4691,8223671,8973,6483,0007,335
Investing Cash Flow
Investing Cash FlowCr
-6,962-2,527-1,407-3,2821,107-1,2401,292-1,287-1,712-4,172-3,865
Financing Cash Flow
Financing Cash FlowCr
5,836433-1,492744-891-1,885-1,572-337-2,1841,732-846
Net Cash Flow
Net Cash FlowCr
-1,5082,019-1,148-8721,685-1,30387273-2485602,624
Free Cash Flow
Free Cash FlowCr
-3424,1501,8151,6911,4711,8283744362,7321,3475,527
CFO To PAT
CFO To PAT%
-16.9160.4677.8319.8-367.3148.4-24.3423.8188.590.7136.9
CFO To EBITDA
CFO To EBITDA%
-10.491.555.665.162.471.0167.9110.396.056.889.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-3824,1141,7511,6661,4691,8223671,8973,6483,0007,335
Investing Cash Flow
Investing Cash FlowCr
-6,962-2,527-1,407-3,2821,107-1,2401,292-1,287-1,712-4,172-3,865
Financing Cash Flow
Financing Cash FlowCr
5,836433-1,492744-891-1,885-1,572-337-2,1841,732-846
Net Cash Flow
Net Cash FlowCr
-1,5082,019-1,148-8721,685-1,30387273-2485602,624
Free Cash Flow
Free Cash FlowCr
-3424,1501,8151,6911,4711,8283744362,7321,3475,527
CFO To PAT
CFO To PAT%
-16.9160.4677.8319.8-367.3148.4-24.3423.8188.590.7136.9
CFO To EBITDA
CFO To EBITDA%
-10.491.555.665.162.471.0167.9110.396.056.889.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
66,69865,24433,29133,44426,71346,31833,90629,47673,72292,5231,05,73292,099
Price To Earnings
Price To Earnings
30.425.5132.455.238.168.638.528.219.817.2
Price To Sales
Price To Sales
4.73.82.12.31.73.02.11.83.74.13.83.0
Price To Book
Price To Book
6.04.82.52.42.13.42.82.45.25.44.73.8
EV To EBITDA
EV To EBITDA
19.816.112.315.912.119.4168.919.019.918.013.110.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.358.654.154.952.852.448.747.855.659.063.863.8
OPM
OPM%
26.125.919.917.515.316.91.310.319.023.229.230.1
NPM
NPM%
16.114.81.63.5-2.68.1-9.22.79.714.619.217.0
ROCE
ROCE%
18.517.23.77.86.79.6-7.55.815.919.025.125.4
ROE
ROE%
20.319.01.93.8-3.28.9-12.43.613.519.223.921.7
ROA
ROA%
10.09.61.01.9-1.65.2-6.91.98.111.314.013.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
66,69865,24433,29133,44426,71346,31833,90629,47673,72292,5231,05,73292,099
Price To Earnings
Price To Earnings
30.425.5132.455.238.168.638.528.219.817.2
Price To Sales
Price To Sales
4.73.82.12.31.73.02.11.83.74.13.83.0
Price To Book
Price To Book
6.04.82.52.42.13.42.82.45.25.44.73.8
EV To EBITDA
EV To EBITDA
19.816.112.315.912.119.4168.919.019.918.013.110.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.358.654.154.952.852.448.747.855.659.063.863.8
OPM
OPM%
26.125.919.917.515.316.91.310.319.023.229.230.1
NPM
NPM%
16.114.81.63.5-2.68.1-9.22.79.714.619.217.0
ROCE
ROCE%
18.517.23.77.86.79.6-7.55.815.919.025.125.4
ROE
ROE%
20.319.01.93.8-3.28.9-12.43.613.519.223.921.7
ROA
ROA%
10.09.61.01.9-1.65.2-6.91.98.111.314.013.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,14,3161,10,0771,03,51092,09974,73361,99459,386
Close PriceClose₹1,415.002,665.001,799.002,014.002,648.005,185.00364.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE39.4549.0526.0917.2451.4929.98121.87
Price To SalesPS4.067.162.803.004.693.973.41
RevenueRevenueCr28,13915,37936,91330,74615,93715,63217,415
Revenue Growth TTMRev Gr TTM%-0.7%13.5%13.5%24.2%-0.1%12.5%5.7%
PAT Growth TTMPAT Gr TTM%-47.4%27.6%16.5%20.1%43.7%-13.2%-55.4%
Market CapitalizationMkt CapCr1,14,3161,10,0771,03,51092,09974,73361,99459,386
Close PriceClose₹1,415.002,665.001,799.002,014.002,648.005,185.00364.40
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE39.4549.0526.0917.2451.4929.98121.87
Price To SalesPS4.067.162.803.004.693.973.41
RevenueRevenueCr28,13915,37936,91330,74615,93715,63217,415
Revenue Growth TTMRev Gr TTM%-0.7%13.5%13.5%24.2%-0.1%12.5%5.7%
PAT Growth TTMPAT Gr TTM%-47.4%27.6%16.5%20.1%43.7%-13.2%-55.4%
Interviews